MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circep.111.966754

Медицинская библиотека · Circulation. Arrhythmia and electrophysiology · 2011

Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?

Koyak Zeliha, de Groot Joris R, Van Gelder Isabelle C, Bouma Berto J, van Dessel Pascal F H M, Budts Werner, van Erven Lieselot, van Dijk Arie P J, Wilde Arthur A M, Pieper Petronella G, Sieswerda Gertjan T, Mulder Barbara J M

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The value of implantable cardioverter defibrillators (ICDs) in adults with congenital heart disease (CHD) is unknown. We investigated the long-term outcome after ICD implantation and developed a simple risk stratification score for ICD therapy.

METHODS AND

RESULTS

A total of 136 adults with CHD and ICD (mean age±SD, 41±13 years; 67% male) were identified from 10 tertiary referral centers in the Netherlands and Belgium. The indication for ICD implantation was primary prevention in 50% of patients. Diagnoses included tetralogy of Fallot (51%), septal defects (20%), (congenitally corrected) transposition of the great arteries (13%), and other (16%). Thirty-nine patients (29%) received appropriate ICD shocks during a median follow-up of 4.6 years. Secondary prevention indication (hazard ratio [HR], 3.6; 95% CI, 1.3-9.5; P=0.009), coronary artery disease (HR, 2.7; 95% CI, 1.0-7.2; P=0.042), and symptomatic nonsustained ventricular tachycardia (NSVT; HR, 9.1; 95% CI, 2.8-29.2; P=0.001) were associated with appropriate ICD shocks. A risk score was developed to evaluate the likelihood of appropriate ICD shocks. The 8-year survival curve to first appropriate shocks was 94%, 57%, and 26% for low-, intermediate-, and high-risk patients, respectively. In primary prevention, symptomatic NSVTs (HR, 8.0; 95% CI, 2.3-27.1; P=0.001) and subpulmonary ventricular dysfunction (HR, 3.0; 95% CI, 1.2-12.6; P=0.02) were associated with appropriate shocks in univariable analysis. Inappropriate shocks occurred in 41 patients (30%). In addition, 40 patients (29%) experienced 45 implantation-related complications.

CONCLUSIONS

Adults with CHD and ICDs receive high rates of appropriate and effective shocks. Patients with secondary prevention indication, coronary artery disease, and symptomatic NSVT are at highest risk of receiving appropriate ICD shocks. ICD implantation is accompanied by considerable morbidity, including inappropriate shocks and procedure- related complications.

Для цитирования: Koyak Zeliha, de Groot Joris R, Van Gelder Isabelle C, Bouma Berto J, van Dessel Pascal F H M, Budts Werner, van Erven Lieselot, van Dijk Arie P J, Wilde Arthur A M, Pieper Petronella G, Sieswerda Gertjan T, Mulder Barbara J M. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?. Circulation. Arrhythmia and electrophysiology. 2011. DOI: 10.1161/circep.111.966754.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.